VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia

VolitionRx (VNRX) announced the appointment of two new centralized laboratory providers of its Nu.Q Vet Cancer test in the U.S. and Asia, further expanding access to its canine cancer early detection tool. Midwest Veterinary Laboratory, a full-service independent reference laboratory in the U.S., will be offering the Nu.Q Vet Cancer test to its customers across all 50 states from February 2026. Bioguard, a global animal health diagnostics company is now offering the Nu.Q Vet Cancer Test through its Animal Health Diagnostic Center, the first certified ISO/IEC 17025 animal disease testing laboratory in Taiwan and China.